|
|
|
41
|
5691E
|
ACYCLOVIR 50MG/ML INJ (KWA) (BQ)
|
ACYCLOVIR
|
ACYCLOVIR
|
10ML VIAL
|
BQ
|
4.89
|
4.893
|
VIAL
|
15
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
4
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
5691F
|
ZOVIRAX 50MG/ML INJ (GSK/COL) ACYCLOVIR
|
ACYCLOVIR
|
ZOVIRAX
|
5X5ML
|
BQ
|
437.87
|
87.57
|
INJECTION
|
0
|
VIAL
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5691F
|
ZOVIRAX 50MG/ML INJ (GSK) ACYCLOVIR (C)
|
ACYCLOVIR
|
ZOVIRAX
|
5X5ML
|
C
|
481.63
|
96.3265
|
VIAL
|
15
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
4
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
5691M
|
ACYCLOVIR 50MG/ML INJ (CHC/ATB)
|
ACYCLOVIR
|
ACYCLOVIR
|
10ML
|
BQ
|
9.05
|
9.05
|
INJECTION
|
0
|
VIAL
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
Price Change
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2021-12-03
|
|
|
|
42
|
5691S
|
SIMPLOVIR 50MG/ML INJ (INC) ACYCLOVIR
|
ACYCLOVIR
|
SIMPLOVIR
|
500MG VIAL
|
BQ
|
11.93
|
11.93
|
VIAL
|
15
|
VIAL
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
42
|
5691T
|
ACYCLOVIR 50MG/ML INJ (FSB)
|
ACYCLOVIR
|
ACYCLOVIR
|
10ML
|
BQ
|
2.36
|
2.36
|
VIAL
|
15
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-03-05
|
|
|
|
40
|
5692K
|
ACYCLOVIR 5% OINT (TOR/AHI)
|
ACYCLOVIR
|
ACYCLOVIR
|
15G
|
C
|
69.32
|
69.32
|
OINT
|
0
|
TUBE
|
TOR
|
TORRENT PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5692K
|
ACYCLOVIR 5% OINT (TOR)
|
ACYCLOVIR
|
ACYCLOVIR
|
15G
|
C
|
69.32
|
69.3173
|
TUBE
|
2
|
BOX
|
TOR
|
TORRENT PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
42
|
5692N
|
APO-ACYCLOVIR 5% OINT (APO)
|
ACYCLOVIR
|
APO-ACYCLOVIR
|
4G
|
A
|
6.39
|
6.39
|
TUBE
|
2
|
TUBE
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
56937
|
APO-ACYCLOVIR 200MG TAB (APO/COL)
|
ACYCLOVIR
|
APO-ACYCLOVIR
|
100'S
|
A
|
14.35
|
0.14
|
TABLET
|
50
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
56937
|
APO-ACYCLOVIR 200MG TAB (APO)
|
ACYCLOVIR
|
APO-ACYCLOVIR
|
100'S
|
A
|
14.49
|
0.14
|
TAB
|
50
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
5693AW
|
VALTREX 500MG TAB (GSK/COL) VALACYCLOVIR
|
VALACYCLOVIR
|
VALTREX
|
10'S
|
C
|
61.90
|
6.19
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5693AW
|
VALTREX 500MG TAB (GSK) VALACYCLOVIR (C)
|
VALACYCLOVIR
|
VALTREX
|
10'S
|
C
|
68.07
|
6.8067
|
TAB
|
42
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
41
|
5693AZ
|
ACYCLOVIR 200MG TAB (CPP) ACYCLOVIR
|
ACYCLOVIR
|
ACYCLOVIR
|
25'S
|
A
|
3.18
|
0.1272
|
TAB
|
50
|
BOX
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
41
|
5693CG
|
CYCLOVAX 200MG TAB (REM) ACYCLOVIR (C)
|
ACYCLOVIR
|
CYCLOVAX
|
3X10
|
C
|
4.49
|
0.1495
|
TAB
|
50
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
5693DU
|
PMS-VALACYCLOVIR 500MG CAP (PMS/COL)
|
VALACYCLOVIR
|
PMS-VALACYCLOVIR
|
100'S
|
A
|
59.80
|
0.60
|
CAPSULE
|
42
|
CAP
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5693EC
|
ZOVIRAX 200MG TAB (GSK/COL) ACYCLOVIR
|
ACYCLOVIR
|
ZOVIRAX
|
25'S
|
C
|
62.90
|
2.52
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5693EZ
|
ACYCLOVIR 200MG TAB (CHC/ATB)
|
ACYCLOVIR
|
ACYCLOVIR
|
100'S
|
A
|
16.58
|
0.17
|
TABLET
|
50
|
TAB
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5693FA
|
APO-ACYCLOVIR 200MG TAB (APO)
|
ACYCLOVIR
|
APO-ACYCLOVIR
|
100'S
|
A
|
14.49
|
0.1449
|
TAB
|
50
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
41
|
5693FB
|
APO-VALCYCLOVIR 500MG TAB (APO) VAL
|
VALACYCLOVIR
|
APO-VALCYCLOVIR
|
100'S
|
A
|
67.88
|
0.6788
|
TAB
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|